Depo-Provera is a medication primarily used to treat conditions like,, and painful periods, among others.
It is not approved for use by women, but is prescribed by doctors to women who have experienced them through oral contraceptive methods (also called Depo-Provera pills). Depo-Provera pills are effective at preventing pregnancy, but the dose of the medication varies depending on the woman's age and health.
It is essential to talk to your doctor about any concerns or questions you may have regarding your Depo-Provera pills.
You can ask your doctor about any existing health conditions or allergies you may have. Your doctor will discuss the possible effects of Depo-Provera on the body.
You may also need a blood test to check for pregnancy if you are a woman.
You should also inform your doctor about any existing medical conditions you have, as well as the symptoms you are currently experiencing with the use of Depo-Provera.
If you become pregnant while using Depo-Provera, your doctor will need to be consulted immediately.
If you are concerned about your health or your symptoms, your doctor will discuss your options with you.
If you are experiencing symptoms of a blood clot, such as pain or pressure, the doctor will recommend that you discontinue use of Depo-Provera pills and seek immediate medical attention. This is not a cause for concern and is a necessary precaution.
If you are pregnant, you should not use Depo-Provera until you have completed the necessary precautions.
Depo-Provera is available in both oral contraceptive injection and vaginal ring forms. It is recommended that you take Depo-Provera 150 mg injection every three months, to prevent pregnancy.
You should avoid using Depo-Provera if you are experiencing any signs of bleeding or pain during intercourse, such as a heavy menstrual period or spotting.
You should continue to use Depo-Provera even after you have completed the following steps to prevent pregnancy:
Depo-Provera 150 mg injection is a prescription-only contraceptive injection available for injection into a woman's uterus.
The method is a single-dose contraceptive pill, and it is the only method of contraception that contains a single progestin.
You can use it for injections at the same time as other contraceptive pills or rings. If you are using Depo-Provera at the same time as other contraceptives, you should use the same method twice a week for 12 weeks.
You can also use the contraceptive ring Depo-Provera 150 mg injection at any time as long as your doctor recommends using the injection.
Q: What is PROVERA 10MG TABLET used for?
A: PROVERA 10MG TABLET is used in to maintain a balance on menstrual cycle and controls abnormal tissue growth in uterus.
Q: How does PROVERA 10MG TABLET regulate menstrual cycle?
A: PROVERA 10MG TABLET works by stopping the production of gonadotropin hormone, which is responsible for maturation of cells in the ovary and the process of releasing mature egg from the ovary (ovulation) to avoid pregnancy. This kind of action provides relief from unpleasant period symptoms.
Q: For how long should you take PROVERA 10MG TABLET?
A: Your doctor might advise you on how long you should continue to take PROVERA 10MG TABLET. You will need to consult your doctor from time to time to review your management and assess your symptoms. Do not stop taking PROVERA 10MG TABLET on your own.
Q: Can PROVERA 10MG TABLET be used during pregnancy?
A: PROVERA 10MG TABLET is not recommended for use in pregnant women as it can affect the developing baby. If you think you are pregnant or planning to have baby or have a history of repeated miscarriage, inform your doctor before taking PROVERA 10MG TABLET. Use other methods of contraceptives while taking this medicine.
Q:IsPROVERA 10MG TABLET safe to use in patients with heart problems?
A: PROVERA 10MG TABLET is not recommended for use if patient had a stroke or heart attack in the past years. It should be taken with caution in patients with heart problems and high blood pressure. Consult your doctor before taking PROVERA 10MG TABLET.
Howhelping to feel for PROVERA 10MG TABLETinamne-TSideof ActionPROVERA 10MG TABLET (provera)MMCThe committee said that it was important to remember that patients with heart problems are at increased risk of endometrial cancer and that there are significant benefits to taking therapy that outweigh the risks. It also noted that there are specific guidelines for the management of patients with heart problems and patients taking medications for heart problems should be monitored closely.
A: PROVERA 10MG TABLET is given by meropenem or provera as a 10 mg tablet, taken as needed, every 4 hours. You should take this medicine about 1 hour before you plan to have sex. If you have certain medical conditions, lab support or prolonged use of PROVERA 10MG TABLET may prevent you from having symptoms.
The maximum dose for oral administration was one tablet in 2003.
The committee did not have access to this information and the information was not made available.
Side effects of PROVERA 10MG TABLET in inpCTThis product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$26.95
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Product(s) on HealthylifeHealthylife is unable to provide any information on the country of origin of any of our products.
Healthylife does not endorse or disapprove of any particular product mentioned on our policies.
Healthylife PolicyHealthylife.com.au advises that you should contact your doctor or other healthcare professional if you have experienced any medical conditions,�allergic reactions," or any other medical condition. You should also note that Healthylife does not recommend that you discount this or any other products through this policy. You should consult your doctor or another healthcare professional before taking any medication and for at least 6 months after your last dose of any medication to ensure that you are fully compliant with Healthylife's usage instructions. You should also note that you are advised not to have any sexual activity after taking this policy and that Healthylife does not recommend the use of these products. If you do have sexual activity, you should refrain from using or abusing these products and kindly consult your doctor or another healthcare professional. Healthylife does not endorse any specific products/brand names/patents origoritsers. Healthylife reserves the right to adjust the prices of any applicable discount or coupons when applicable.
Healthylife offers a cost-effective alternative to Depo Provera. Healthylife offers a cost-effective alternative to Depo-Provera. If you have any questions about this or any other healthcare available, contact your doctor.
Product variants & Availability
This prescription medication is supplied by Healthylife Pharmacy, an independently owned and operated pharmacy business. Healthylife Pharmacy, an independently owned and operated business, has made every effort to find a suitable alternative to Depo Provera, but has always made every attempt to obtain a suitable alternative. However, as with any medication, it is important that you follow the instructions of your doctor and not suffer from any side effects. If you have any questions about this medication, please do not hesitate to contact our pharmacist or contact our customer service by toll free number (×½) 866romptu during your stay in our clinical facility.
Healthylife is unable to provide any information on the currently available products.
A large and extensive study of women using long-acting depot medroxyprogesterone acetate (DMPA) injection in the first 3 months after menopause is underway. DMPA is a hormone replacement therapy containing an injectable progestogen that helps control body weight, increase the levels of estrogen, and prevent ovulation. It is administered intramuscularly by a healthcare professional at a dose of 0.5 mg/kg, and is given intramuscularly at a dose of 5 mg/kg, and once weekly for up to three months. DMPA is not approved for use by women who have had an endometrial cancer diagnosis after menopause, and is not used in women who have a history of infertility.
A small study of 13 women with endometrial cancer has been published in the Journal of Clinical Endocrinology, in June 2019. The study included women with endometrial carcinoma who were either randomized and managed at the Women's Hospital of Philadelphia or had not been treated with DMPA for a year.
In a small randomized, double-blind, placebo-controlled trial, women taking DMPA for 3 months had a significant increase in their weight, and the weight gain was also greater than that observed in the randomized control group, which may be related to the increased risk of endometrial cancer in DMPA users. In addition, women with endometrial cancer had a greater number of endometrial cancers and more aggressive endometrial cancers.
In a study of over 150 women, DMPA users also experienced a significantly increased risk of endometrial cancer compared with women not treated with DMPA.
In a study of 13 women with endometrial cancer who had a history of endometrial cancer, DMPA users had a greater number of endometrial cancers and more aggressive endometrial cancers compared with women not treated with DMPA.
A study of 10 women with a history of endometrial cancer that had been treated with DMPA for five years and a history of endometrial cancer was published in the Journal of Clinical Endocrinology, in June 2019.
The study, called the Women's Hormone Replacement Therapy Study (WHRT), is an open-label, randomized, double-blind, controlled trial of women who have used DMPA for five years or more and have not been treated with DMPA for a year. In addition, the study also includes women who have been given a DMPA injection, which is used in the treatment of endometrial cancer.
The study was published in the New England Journal of Medicine in April 2023 and the results are published in the Journal of Clinical Endocrinology, in July 2019.
The women who took DMPA for five years were assigned to receive either 10 mg of DMPA intramuscularly or 10 mg of DMPA intramuscularly every three months for five years, and then were assigned to receive either 10 mg or 20 mg of DMPA intramuscularly for five years.
In the five-year trial, the women who took DMPA for five years had an increase in their weight compared with the women who took placebo. The women who took DMPA for five years had a significantly greater number of endometrial cancers compared with the women who took placebo, which was an increase in weight gain. The women who took placebo had a significantly greater number of endometrial cancers compared with the women who took DMPA. The women who took DMPA for five years had a significantly greater number of endometrial cancers compared with the women who took placebo.
A study of 8 women with endometrial cancer who had been treated with DMPA for three years for five years was published in the Journal of Clinical Endocrinology, in July 2019.
The study was published in the Journal of Clinical Endocrinology, in June 2019.
The women who received DMPA for three years experienced a significant weight gain, and the women who received DMPA for three years experienced a weight gain.
The women who received DMPA for three years experienced a significantly greater number of endometrial cancers and more aggressive endometrial cancers compared with the women who received placebo, which was an increase in the number of endometrial cancers.
The women who received DMPA for five years experienced a significant weight gain, and the women who received DMPA for five years experienced a weight gain.
Stade de France Pharmacy